Periscope Capital’s Bellevue Life Sciences Acquisition Corp. Rights BLACR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-485,500
| Closed | -$65.2K | – | 238 |
|
|
2024
Q4 | $65.2K | Sell |
485,500
-3,100
| -0.6% | -$416 | 0.04% | 78 |
|
|
2024
Q3 | $57.2K | Hold |
488,600
| – | – | 0.03% | 80 |
|
|
2024
Q2 | $58.9K | Sell |
488,600
-418,400
| -46% | -$50.4K | 0.02% | 125 |
|
|
2024
Q1 | $130K | Hold |
907,000
| – | – | 0.03% | 141 |
|
|
2023
Q4 | $159K | Hold |
907,000
| – | – | 0.03% | 174 |
|
|
2023
Q3 | $209K | Buy |
907,000
+588,600
| +185% | +$135K | 0.02% | 242 |
|
|
2023
Q2 | $60.9K | Buy |
318,400
+85,400
| +37% | +$16.3K | ﹤0.01% | 399 |
|
|
2023
Q1 | $39.2K | Buy |
+233,000
| New | +$39.2K | ﹤0.01% | 567 |
|